Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2024-03-10 23:15 Tx date 2024-03-04 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+2,222 vol |
10,801 | |
Filed 2023-12-14 21:24 Tx date 2023-11-10 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-56,883 vol |
7,110 | |
Filed 2023-12-14 21:23 Tx date 2023-03-19 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-12,776 vol |
77,224 | |
Filed 2023-12-14 21:20 Tx date 2023-11-10 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-26,667 vol |
8,579 | |
Filed 2023-12-14 21:19 Tx date 2023-11-10 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-19,264 vol |
35,246 | |
Filed 2023-12-14 21:18 Tx date 2023-11-10 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-22,714 vol |
54,510 | |
Filed 2022-06-23 13:00 Tx date 2022-06-06 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
||
Filed 2022-06-09 22:42 Tx date 2022-06-06 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
||
Filed 2022-06-09 22:42 Tx date 2022-06-06 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
120,000 | |
Filed 2022-06-08 18:24 Tx date 2022-06-06 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$48,000
+30,000 vol $1.60 each |
90,000 | |
Filed 2022-06-08 17:57 Tx date 2021-09-24 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-686,291 vol |
63,993 | |
Filed 2021-10-06 10:52 Tx date 2021-09-24 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-686,376 vol |
||
Filed 2021-12-21 21:46 Tx date 2021-12-21 |
$XRX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$55,044
+21,671 vol $2.54 each |
60,000 | |
Filed 2021-10-06 10:55 Tx date 2021-09-24 |
$XRX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-274,447 vol |
38,329 | |
Filed 2021-10-06 10:53 Tx date 2021-09-24 |
$XRX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-137,224 vol |
312,776 | |
Filed 2021-10-06 10:52 Tx date 2021-09-24 |
$XRX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-686,376 vol |
63,908 | |
Filed 2021-03-01 10:04 Tx date 2021-02-26 |
$XRX
XORTX Therapeutics Inc. (formerly: APAC Resources Inc.) |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$89,285
+357,142 vol $0.25 each |
750,284 | |
Filed 2021-03-01 10:03 Tx date 2021-02-26 |
$XRX
XORTX Therapeutics Inc. (formerly: APAC Resources Inc.) |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-357,142 vol |
0 | |
Filed 2020-06-27 22:31 Tx date 2020-06-23 |
$XRX
XORTX Therapeutics Inc. (formerly: APAC Resources Inc.) |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$42,000
+300,000 vol $0.14 each |
450,000 | |
Filed 2020-06-27 22:31 Tx date 2018-01-25 |
$XRX
XORTX Therapeutics Inc. (formerly: APAC Resources Inc.) |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
150,000 | ||
Filed 2020-03-10 21:38 Tx date 2020-02-28 |
$XRX
XORTX Therapeutics Inc. (formerly: APAC Resources Inc.) |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+357,142 vol |
357,142 | |
Filed 2020-03-10 21:38 Tx date 2018-01-25 |
$XRX
XORTX Therapeutics Inc. (formerly: APAC Resources Inc.) |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-03-10 21:37 Tx date 2020-02-28 |
$XRX
XORTX Therapeutics Inc. (formerly: APAC Resources Inc.) |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$49,999
+357,142 vol $0.14 each |
393,142 | |
Filed 2020-03-03 17:47 Tx date 2020-02-27 |
$MMED
Mind Medicine (MindMed) Inc. (formerly Broadway Gold Mining Ltd.) |
Van Damme, Paul Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options incentive stock options
50 - Grant of options
|
$33,000
+100,000 vol $0.33 each |
100,000 | |
Filed 2020-03-03 17:46 Tx date 2020-02-27 |
$MMED
Mind Medicine (MindMed) Inc. (formerly Broadway Gold Mining Ltd.) |
Van Damme, Paul Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options incentive stock options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-01-28 13:37 Tx date 2020-01-26 |
$QPT
Quest PharmaTech Inc. |
Van Damme, Paul Joseph
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
52 - Expiration of options
|
$-10,000
-100,000 vol $0.10 each |
450,000 | |
Filed 2018-09-05 Tx date 2018-09-05 |
$XRX
XORTX Therapeutics Inc. (formerly: APAC Resources Inc.) |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,300
+11,500 vol $0.20 each |
36,000 | |
Filed 2018-09-01 Tx date 2018-08-31 |
$XRX
XORTX Therapeutics Inc. (formerly: APAC Resources Inc.) |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,500
+7,500 vol $0.20 each |
24,500 | |
Filed 2018-08-31 Tx date 2018-08-30 |
$XRX
XORTX Therapeutics Inc. (formerly: APAC Resources Inc.) |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,700
+8,500 vol $0.20 each |
17,000 | |
Filed 2018-08-30 Tx date 2018-08-29 |
$XRX
XORTX Therapeutics Inc. (formerly: APAC Resources Inc.) |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$500.00
+2,500 vol $0.20 each |
8,500 | |
Filed 2018-08-29 Tx date 2018-08-28 |
$XRX
XORTX Therapeutics Inc. (formerly: APAC Resources Inc.) |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,200
+6,000 vol $0.20 each |
6,000 | |
Filed 2018-04-11 Tx date 2018-01-25 |
$
XORTX Therapeutics Inc. (formerly, APAC Resources Inc.) |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-04-11 Tx date 2018-01-25 |
$
XORTX Therapeutics Inc. (formerly, APAC Resources Inc.) |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-02-02 Tx date 2018-01-25 |
$XRX
XORTX Therapeutics Inc. (formerly: APAC Resources Inc.) |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-01-29 Tx date 2018-01-25 |
$
XORTX Therapeutics Inc. (formerly, APAC Resources Inc.) |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-11-09 Tx date 2015-11-04 |
$ECT
Ellipsiz Communications Ltd. (formerly NXA Inc.) |
Van Damme, Paul Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-610,200 vol |
67,800 |